Hormone Receptor Positive Malignant Neoplasm of Breast Clinical Trials

20 clinical trials for Hormone Receptor Positive Malignant Neoplasm of Breast across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors — RECRUITING · PHASE1
• Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer — RECRUITING · NA
• A Study of Revaree Plus in People With Breast Cancer — RECRUITING · PHASE4
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study — RECRUITING
• BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors — COMPLETED · PHASE1
• Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer — COMPLETED · PHASE2
• Comparison of the Breast Tumor Microenvironment — ACTIVE_NOT_RECRUITING
• Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer. — COMPLETED · PHASE1
• Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer — COMPLETED · PHASE3
• Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer — COMPLETED · PHASE1
• The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population — COMPLETED · NA
• Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer — WITHDRAWN · PHASE1
• Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane — OTHER · NA
• Prospective Thinking in Hormone-Responsive Breast Cancer — COMPLETED · NA
• Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer — OTHER · PHASE2
• Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC — OTHER · PHASE2
• Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer — COMPLETED · PHASE2
• Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab — COMPLETED · PHASE4
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — COMPLETED
• Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer — OTHER · PHASE2

Refine this search